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Abstract
Background: Anaemia may increase risk of dementia or cognitive decline. There is also evidence
that high haemoglobin levels increase risk of stroke, and consequently possible cognitive
impairment. The elderly are more at risk of developing dementia and are also more likely to suffer
from anaemia, although there is relatively little longitudinal literature addressing this association.
Methods: To evaluate the evidence for any relationship between incident cognitive decline or
dementia in the elderly and anaemia or haemoglobin level, we conducted a systematic review and
meta-analyses of peer reviewed publications. Medline, Embase and PsychInfo were searched for
English language publications between 1996 and 2006. Criteria for inclusion were longitudinal
studies of subjects aged ≥65, with primary outcomes of incident dementia or cognitive decline.
Other designs were excluded.
Results: Three papers were identified and only two were able to be combined into a meta-analysis.
The pooled hazard ratio for these two studies was 1.94 (95 percent confidence intervals of 1.32–
2.87) showing a significantly increased risk of incident dementia with anaemia. It was not possible
to investigate the effect of higher levels of haemoglobin.
Conclusion: Anaemia is one factor to bear in mind when evaluating risk of incident dementia.
However, there are few data available and the studies were methodologically varied so a cautionary
note needs to be sounded and our primary recommendation is that further robust research be
carried out.
Background
Low and high levels of haemoglobin may indicate
increased risk of morbidity beyond the immediate cause
of haemoglobin abnormality. Higher haemoglobin levels
and polycythemia are associated with circulatory distur-
bances and risk of cardiovascular events, mortality and
stroke [1,2]. Low levels of haemoglobin and the presence
of anaemia have been found to be risk factors for poor
mobility, increased frailty and decreased executive func-
tion in women [3-5], a relationship with poorer outcome
after sub arachnoid haemorrhage [6] decreased motor
performance [7] and increased risk of death [8]. Further-
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(participants aged 65 or over) showed a 'reverse J' shaped
curve relationship between mortality and haemoglobin
levels [9]. Both lower (< 13.7 gm/dl for women and < 12.6
gm/dl for men) and higher (> 14.1 gm/dl for women and
> 15.6 gm/dl for men) haemoglobin levels conferred a sig-
nificantly increased risk of death. In the higher category
this was a statistically significant 17 percent increase [9].
In the Women's Health and Aging Study [WHAS] the ref-
erence value used was > 12 to < 15 and the reverse J shape
was seen although only anaemia (not polycythaemia) was
significantly associated with mortality [3-5]. Anaemia
prevalence rates are reported at around 25 percent [10-12]
(30% in men 17% in women) of individuals over the age
of 85 when defined according to the WHO criteria [13]
and the literature generally agrees that a fall in haemo-
globin levels in the eighth decade of life occurs and that
this may be part of normal ageing [14,15].
The elderly, particularly the very elderly, aged eighty and
over, are the fastest growing part of the population world-
wide [16], and are at high risk of dementia and related
cognitive decline. If haemoglobin levels are related to
either incident or prevalent dementia or cognitive decline,
there may be a possibility of intervention to prevent or
ameliorate onset of dementia; important both for poten-
tial sufferers, carers, and, in economic terms [17]. A previ-
ous review focusing on the elderly did not provide meta-
analytic data, did not examine higher levels of haemo-
globin and did not focus on dementia or cognitive decline
[18]. Since that review, the literature has grown and the
very elderly have become even more of an important
group in society, we have therefore performed a system-
atic review, focused on dementia and cognitive decline.
Objective: to review the evidence for a relationship
between haemoglobin levels and cognitive decline/
dementia in the elderly via a systematic review; and to
evaluate the strength of the findings taking into account
the methodological differences in constituent studies.
Hypotheses
Haemoglobin as a risk factor
1: That anaemia (labelled as such in the literature) or as
defined by the WHO as low levels of haemoglobin (< 12
gm/dl women and < 13 gm/dl men) will be predictive of
lower cognitive function and or dementia.
2: That high haemoglobin (> 14.1 gm/dl women and >
15.6 gm/dl men) will be predictive of lower cognitive
function and or dementia.
Methods
In order to evaluate the evidence that was available in the
scientific literature, a review was carried out using system-
atic review methodology in order to examine the literature
in the most thorough and unbiased manner. Search terms
'anaemia' or 'anemia' or 'haemoglobin' or 'hemoglobin'
and 'dementia' or vascular dementia' or 'multi infarct
dementia' or Alzheimer's disease' or 'cognitive impair-
ment' or 'cognitive decline' were used as keywords and the
databases Medline, Embase and Psychinfo were searched
for English language publications relating to human pop-
ulations and occurring between 1996 and March 2006.
The last 10 years were chosen as research methodology
has evolved and computing power changed rapidly prior
to this time. When available, standard search categories
were also used as matched the above terms. All searches
were limited to subjects aged 65 and over. See figure 1 for
details. Two researchers appraised all abstracts independ-
ently; any discrepancies in decisions were discussed to
achieve a unanimous choice of articles.
Studies were ranked on a methodological basis with ran-
domised studies first, followed by case control and epide-
miological population studies, and quality assessed using
key factors including appropriate design, recruitment,
analysis and provision of suitable information relating to
key aspects of the study. Case studies, letters, consensus
opinion from conferences and expert opinions or editori-
als were not included. In order to aid investigation of cau-
sality only longitudinal studies were included. Studies
reporting results that could be used in a meta-analysis
were analysed accordingly and tests for heterogeneity car-
ried out.
Results
From an initial 21 papers identified as relevant based on
abstract alone only three remained so after full evaluation.
Showing results of systematic reviewFigure 1
Showing results of systematic review.
Medline number 
identified 36 
Psychinfo number 
identified 3 
Embase number 
identified 91 
Medline number Psychinfo number Embase number 
possibly relevant to 
research question 14 
(judged on abstract 
alone)
possibly relevant to 
research question 2 
(judged on abstract 
alone)
possibly relevant to 
research question 12 
(judged on abstract 
alone)
7 papers reporting on 8 studies identified after overlap between search 
engines accounted for and full text examined. 
15 rejected (inappropriate content or insufficient methodological detail) 
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trolled trials or intervention studies of any sort. Methodo-
logical details and meta-analytical results are discussed
below. Table 1 details the studies included.
Results of included studies and meta-analysis
For the hypothesis that anaemia or low haemoglobin
was predictive for dementia or cognitive decline; two
studies using the WHO criteria for anaemia found sig-
nificant results.
The population study the Kungsholmen project found a
Hazard Ratio [HR] of 2.0 (95% CI 1.0–3.8) for incident
dementia with anaemia [19]. The retrospective case con-
trol study from Beard et al [20] found a similar result for
Alzheimer's disease which was significant only in women
(Odds Ratio [OR] 1.96 (95%CI 1.11–3.47)) although
men showed a similar but non-significant effect OR 1.81
(95% CI 0.75–4.39). An additional analysis from the
Kungsholmen population found an even stronger rela-
tionship with haemoglobin values below 11.7 g/dl for
men and 11.6 g/dl for women respectively (The fifth per-
centile from their population). HR 2.2 (95% CI 1.0–4.9).
[19]. No other evidence relating to low haemoglobin con-
centrations other than those defined above was available.
It was only possible to combine two longitudinal papers
in a meta-analysis to examine the relationship between
anaemia and dementia (figure 2). The analysis of hetero-
geneity was non significant (p = 0.98). The pooled ratio
was significant at 1.94 (95% CI 1.32–2.87). It was not fea-
sible to include the cohort study from Beard et al in the
analysis, as it reported only standardised incidence rates
(a ratio of the incidence rate in the study population to
that expected in a 'standard' population) and the source of
the standard population data was unclear [20]. No analy-
ses regarding haemoglobin concentration or cognitive
decline were possible.
Higher haemoglobin gave rise to an odds ratio of 0.86 for
incident cognitive decline in the WHAS study but this was
non significant (95% CI 0.60–1.21) [21].
Methodological considerations
Study design
Two of the longitudinal studies were population based
cohort designs [19,21] with prevalent cases of dementia
plus those with baseline MMSE below 20 and below 24
excluded respectively. The remaining longitudinal study
reported on both a retrospective case control, (where hae-
moglobin values taken up to two years before incident
dementia were used), and a cohort, (where all participants
had newly recognized anaemia and were subsequently
followed up) [20].
Study population
Longitudinal study populations were homogeneous and
from northern Europe [19] and the United States [20,21]
with age ranges or mean ages between 65 and 95 and
therefore old enough to manifest dementia cases. Studies
were relatively large with patient numbers ranging from
255 case control pairs [20] to 1435 followed for a mean of
3.4 years (Standard Deviation [SD]0.5) [19]. Follow up
was less clear with one paper including a cohort follow up
and a case control sub study of incident cases with retro-
spective haemoglobin measurements from the year of and
the year preceding the onset of dementia [20]. Cohort fol-
low up was wide ranging from one day to 7.9 years. This
follow up included patients who had poorer cognition
and who were not included in the analysis, there were
2417 person-years of follow up for the group that were
analysed but the range was not clear [20]. Follow up in the
study including only women was three years [21].
Outcome
There was some heterogeneity in the cognitive assessment
outcome of the identified studies and standardised criteria
were not always applied. Of the three studies, two assessed
dementia and one cognitive decline. Only one, the Kung-
sholmen project, used the standardised Diagnostic and
Statistical Manual of mental disorders [DSM] criteria, (the
[DSM-III-R]) supplemented with information from clini-
cal examination, death certificates and medical records
[19]. Beard et al [20] reported on Alzheimer's disease but
used an adapted form of diagnostic criteria, similar to the
DSM. The WHAS [21] defined cognitive decline as a fall in
MMSE to less than 24.
When measurement of haemoglobin or anaemia was con-
sidered two [19,20] used the WHO criteria for anaemia of
less that 13 g/dl for men and less than 12 g/dl for women
[15]. Atkinson et al reported using haemoglobin measures
but no specific cut off values for anaemia. There was some
discussion in the literature with regard to the utility of the
WHO cut-off values and the Kungsholmen project also
analysed their data using cut off values from the 25th and
5 percentiles (13.5 g/dl men, 12.9 g/dl women and 11.7
g/dl men, 11.6 g/dl women respectively).
Variables adjusted for, and data from subjects not included or lost to 
follow up
Comprehensive adjustments for confounding variables
were made only in the Kungsholmen population (Age,
sex, education, history of hypertension, diabetes, cere-
brovascular disease, heart failure, chronic coronary dis-
ease, COPD, hypothyroidism, chronic renal failure, high
white blood cells, high blood sedimentation rate, low
albumin, low BMI.)[19] and WHAS (Age, race, smoking,
education, no diseases, pulmonary disease, haemoglobin,Page 3 of 6
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Table 1: Characteristics of the three longitudinal studies
Author Population 
Baseline 
numbers 
Descriptives 
Length of follow 
up [fu]
Type of study, 
main outcome
Measurement of 
cognition/
dementia
Measurement of 
haemoglobin 
[hb]/anaemia
Adjusted for: Relationship 
with 
haemoglobin 
[hb]/anaemia
Statistics if 
available. OR = 
Odds Ratio, RR 
= Relative Risk, 
HR = Hazard 
Ratio, (numbers 
in brackets are 
95% confidence 
intervals) In 
order to assess 
the most 
conservative 
finding, results 
used are those 
from the 
adjusted 
analyses unless 
otherwise 
stated.
Atti et al [19] Kungsholmen 
project, Sweden
1435 people 
without 
dementia at 
baseline
Aged 75–95 
years
Mean fu 3.4(0.5 
SD) years
Cohort 
Dementia
Clinical exam, 
review by 
specialist using 
DSM-III-R – 
dementia 
information on 
those who died 
in follow up 
from death 
certificates and 
medical records
WHO criteria 
130 g/L men, 
120 g/L women 
Plus: Lowest 
25th percentile 
135 d/L men & 
129 g/L women 
and lowest 5th 
percentile 117 
g/L & 116 g/L 
women
In those with 
MMSE >= 26: 
Age, sex, 
education, 
history of 
hypertension, 
diabetes, 
cerebrovascular 
disease, heart 
failure, chronic 
coronary 
disease, COPD, 
hypothyroidism, 
chronic renal 
failure, high 
white blood 
cells, high blood 
sedimentation 
rate, low 
albumin, low 
BMI.
Anaemia 
increases risk of 
dementia in 
those with 
MMSE >= 26
Low Hb-below 
130 g/L men & 
120 g/L women 
increases risk of 
dementia
In addition in 
subjects with 
MMSE >= 26....
With Hb < 25th 
percentile HR 
1.2 (0.7–2.0)
With Hb WHO 
criteria HR 2.0 
(1.0–3.8)
With Hb < 5th 
percentile HR 
2.2 (1.0–4.9)
Atkinson et al 
[21]
Women's 
health & ageing 
study 1, USA
558 women 
with MMSE > 
24 and walking 
speed > 0.4 m/s.
Mean age of 
whole study = 
78 yrs(SD8.1)
Fu 3 years
Cohort 
Cognitive 
decline 
(fall in MMSE to 
< 24)
MMSE Hb(g/dl) Age, race, 
smoking, 
education, no 
diseases, 
pulmonary 
disease, hb, 
baseline walking 
speed, baseline 
MMSE, baseline 
IADL, baseline 
ADL
Hb not 
significant 
association with 
cognitive 
decline
Cognitive 
decline
OR 0.86 
(0.60–1.21)
Combined 
physical and 
cognitive 
decline
OR 0.68 
(0.47–0.98)
C.Mary Beard 
et al [20]
Minnesota 1. 
302 incident 
cases of 
Alzheimer's 
Disease [AD] 
with matched 
controls. (255 
pairs analysed) 
Fu: Hb from 
year preceding 
or year of 
dementia onset.
1. Retrospective 
case-control
1. AD identified 
from lists of 
diagnostic 
terms thought 
to include 
dementia – 
diagnostic 
criteria similar 
to DSM. 
controls 
matched by age 
and gender.
WHO criteria 
130 g/L men, 
120 g/L women.
1. Lowest 
measurement 
recorded in 2 yr 
window (onset 
+ preceding yr) 
for cases and 
corresponding 
for controls.
1. age, gender 1. Anaemia 
increases risk of 
AD (not 
significant in 
men)
1.OR 188 
(1.17–3.03)
Men OR 1.81 
(0.75–4.39)
Women OR 
1.96 (1.11–3.47)
2. 618 people 
Aged 65 years+ 
Fu: 5.1 years 
(1 day-7.9 
years)
2. Cohort 
Alzheimer's 
disease [AD]
2. Medical 
records 
reviewed by 
nurse 
abstractor and 
confirmed by 
author
2. A value 
below WHO 
criteria 
between 1985 
& 1989
2.No 
association 
between 
anaemia and 
AD
2.SIR 0.98 
(0.67–1.37)
Men SIR 1.49 
(0.79–2.56)
Women SIR 
0.79 (0.49–1.23)
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baseline ADL) [21] studies.
Of the longitudinal studies only one took into account the
effect of patients who died or left the study [19]. Death
certificates were assessed to identify dementia.
Discussion
The literature available to date in this area is limited and
few data were available for analysis. Despite this, the avail-
able data are considered and presented here in order to
give a robust review of findings to date. It is clear from this
review that further research needs to be carried out in this
area to strengthen the literature case and aid the ability to
draw firm conclusions.
After the search and review process, three longitudinal
studies were identified and considered in this review. The
most robust one of which was the large population study,
the Kungsholmen project [19]. The WHAS [21] was also
of high quality and both found an increased risk of
dementia or cognitive decline at later follow up with anae-
mia at baseline. The third paper reported on two studies
and was weaker in that the length of follow up was varied
for the cohort and unclear for the case control [20] the lat-
ter of which was significant only and supported the rela-
tionship between anaemia and dementia. It was only
possible to combine the case control study from Beard et
al and the Kungsholmen data in a meta-analytic way and
the result was unsurprisingly significant given its constitu-
ent parts.
In reference to our hypotheses, the literature suggests that
low haemoglobin or anaemia increases the risk of inci-
dent dementia or cognitive decline, although the available
studies are few.
There were no data available that allowed examination of
the hypothesis relating to high concentrations of haemo-
globin.
It can be imagined that low haemoglobin or diagnosed
anaemia could impact on future cognitive impairment,
either directly by reducing blood oxygen levels in the
brain over a sustained period of time or possibly by low-
ering a threshold or reserve capacity such that an other-
wise silent cerebrovascular accident such as a small stroke
or transient ischemic attack has a greater impact on subse-
quent cognition. Finally, all such relationships may also
be related to other co-morbidities which could prompt
both anaemia and cognitive impairment.
Although the data here are reflective of the literature there
are many limitations to this investigation. The studies
considered here were heterogeneous in that they looked at
different populations, with one study looking at women
only. Only one of the studies looked at different concen-
trations of haemoglobin in detail and took into account
the possibility that the elderly may have different normal
concentrations. Studies adjusted for confounders to dif-
ferent levels of detail. Definitions of dementia and cogni-
tive decline varied between the studies. Despite many
limitations, the studies did frequently use the standard
WHO definition of anaemia.
Conclusion
All of the above leads us to conclude that further studies
to examine the effect of anaemia and haemoglobin on
dementia and cognitive decline are needed. Such studies
would need to be of large size and longitudinal design
with robust cognitive assessment in the very elderly, in
order to allow the evaluation of possible risks and benefits
in treatment or prevention of dementia or amelioration of
cognitive symptoms both physical and financial.
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